Ozempic for weight loss
is primarily approved for type 2 diabetes management , but its weight loss effects have led many non-diabetics to consider using it. While Ozempic is not officially approved for non-diabetic weight loss, Wegovy , a higher-dose version of semaglutide, is FDA-approved for obesity treatment. Studies show that non-diabetics can lose 10-15% of their body weight with Ozempic, but side effects like nausea, vomiting, and gastrointestinal problems may occur. Long-term safety in non-diabetic individuals is still being researched. Consulting a doctor is essential before use, as self-prescribing can lead to unnecessary risks. Lifestyle changes like diet and exercise remain the best long-term weight management strategies.